Cardiovascular Safety of Patisiran Among Transthyretin Cardiac Amyloidosis: A Meta-analysis

Am J Cardiovasc Drugs. 2025 Jan;25(1):125-127. doi: 10.1007/s40256-024-00699-5. Epub 2024 Nov 22.
No abstract available

Publication types

  • Letter